As of November 2024 Kymera Therapeutics has a market cap of $2.85 Billion USD. This makes Kymera Therapeutics the world's 3668th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 20th, 2024 the market cap of Kymera Therapeutics was reported to be: